Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romão et al and 'SLE patients are not immune to COVID-19: importance of sending the right message across' by Goyal
- PMID: 32404341
- DOI: 10.1136/annrheumdis-2020-217695
Response to: 'Patients with lupus are not protected from COVID-19: a comment' by Sawalha, 'No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit' by Romão et al and 'SLE patients are not immune to COVID-19: importance of sending the right message across' by Goyal
Keywords: autoantibodies; autoimmunity; immune system diseases.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
SLE patients are not immune to covid-19: importance of sending the right message across.Ann Rheum Dis. 2021 Feb;80(2):e23. doi: 10.1136/annrheumdis-2020-217658. Epub 2020 Apr 23. Ann Rheum Dis. 2021. PMID: 32327426 No abstract available.
-
Patients with lupus are not protected from COVID-19.Ann Rheum Dis. 2021 Feb;80(2):e21. doi: 10.1136/annrheumdis-2020-217656. Epub 2020 Apr 24. Ann Rheum Dis. 2021. PMID: 32332075 Free PMC article. No abstract available.
-
No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit.Ann Rheum Dis. 2021 Feb;80(2):e22. doi: 10.1136/annrheumdis-2020-217665. Epub 2020 May 13. Ann Rheum Dis. 2021. PMID: 32404340 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical